from Financial Survival Network
Allison Ostrander of Simpler Trading returns… Cannabis stocks rallied for a second day last Wednesday, buoyed by a historic congressional committee passage of a bill that aims to lift the federal ban on weed, as well as strong gains for Curaleaf after it posted a narrower-than-expected third-quarter loss. Curaleaf’s U.S.-listed shares CURLF, +15.23% CURA, +15.07% were last up 15%, as investors shrugged off its revenue miss. The Massachusetts-based company posted a loss of $6.8 million, or a penny a share, versus losses of $33.7 million, or 9 cents a share in the year-ago period. Revenue rose to $61.8 million from $21.4 million. Analysts polled by FactSet had expected losses of 2 cents a share on revenue of $63.6 million. GMP analyst Robert Fagan, who rates the stock a buy, said the numbers were “largely in line with our relatively high expectations.” The revenue number was below his estimate of $67 million. He highlighted positives, including good cost control, a sequential rise in sales and that vaping fears had only a mue effect on Select’s sales in the quarter. The company acquired the Select brand in May for CS1.27 billion ($954.7 million). Read now: As pot stocks sink, these two guys just raised $120 million to buy Don’t miss: All the excuses cannabis companies are making for an ugly crop of earnings MKM analyst Bill Kirk raised his fair-value estimate on the stock to C$8 from C$6 but stuck with his neutral rating on the stock.
Click Here to Listen to the Audio
Sign up (on the right side) for the instant free Financial Survival Toolkit and free weekly newsletter.
from Kerry Lutz Podcasts – Financial Survival Network https://ift.tt/360qWpA
